BCMA-Targeted Therapy Transforms Multiple Myeloma from Fatal to Chronic Disease with Dr. Robert Rifkin TRANSCRIPT
Download PDFApr 13, 2026
Dr. Robert Rifkin, medical oncologist and hematologist at the University of Colorado in Steamboat Springs. He was also a clinical investigator in the trial that led to the approval of BLENREP, a multiple myeloma drug from GSK. Multiple myeloma is the second most common blood cancer, and while the prognosis has...
Apr 13, 2026
Dr. Robert Rifkin, medical oncologist and hematologist at the University of Colorado in Steamboat Springs. He was also a clinical investigator in the trial that led to the approval of BLENREP, a multiple myeloma drug from GSK. Multiple myeloma is the second most common blood cancer, and while the prognosis has...
AI-Powered Diagnostic Platform Connects Medical Specialists and Patients to Solve Complex Healthcare Cases with Haresh Patel Diagnostic MD AI TRANSCRIPT
Download PDFApr 9, 2026
Haresh Patel, Founder of Diagnostic MD AI, discusses the transformative potential of AI in healthcare diagnostics, particularly for patients with chronic or complex issues. Based on his own struggle to get an accurate diagnosis of an autoimmune condition, Haresh has developed a patient-centric platform...
Apr 9, 2026
Haresh Patel, Founder of Diagnostic MD AI, discusses the transformative potential of AI in healthcare diagnostics, particularly for patients with chronic or complex issues. Based on his own struggle to get an accurate diagnosis of an autoimmune condition, Haresh has developed a patient-centric platform...
How EHR Systems Use Clinical AI to Advance Interoperability with Ben Scharfe Altera Digital Health TRANSCRIPT
Download PDFApr 9, 2026
Ben Scharfe, Executive VP of AI at Altera Digital Health, addresses the evolving regulatory landscape for AI in healthcare, emphasizing AI developers' primary responsibility to ensure transparency so clinicians can understand and verify AI-generated outputs. AI is positioned to be a supportive tool for providers, not...